• Return to Headlines

Hot Stock: Trovagene Inc, Shares Drop 9.0% (TROV)

By Shiri Gupta

Trovagene Inc (NASDAQ:TROV) is one of today's worst performing penny stocks, down 9.0% to $0.42 on 2.0x average daily volume. Trovagene Inc has traded 1.1 million shares thus far today, vs. average volume of 551,000 shares per day. The stock has outperformed the Dow (-9.0% to the Dow's -100.0%) and underperformed the S&P 500 (-9.0% to the S&P's 0.1%) during today's trading.

Potential upside of 137.5% exists for Trovagene Inc, based on a current level of $0.42 and analysts' average consensus price target of $1.00. The stock should run into initial resistance at its 50-day moving average (MA) of $5.27 and subsequent resistance at its 200-day MA of $5.46.

Trovagene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, monitoring of organ, and cell transplantation.

Trovagene Inc share prices have moved between a 52-week high of $5.98 and a 52-week low of $0.23 and are now trading 79% above that low price at $0.42 per share. The 200-day and 50-day moving averages have moved 2.1% lower and 1.58% lower over the past week, respectively.

SmarTrend recommended that subscribers consider buying shares of Trovagene Inc on January 5th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $0.37. Since that recommendation, shares of Trovagene Inc have risen 25.1%. We continue to monitor TROV for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: penny stocks trovagene inc

Ticker(s): TROV